Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
38.01
-0.05 (-0.13%)
At close: Oct 6, 2025, 4:00 PM EDT
38.01
0.00 (0.00%)
After-hours: Oct 6, 2025, 4:00 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.95 billion as of October 6, 2025. Its market cap has increased by 407.21% in one year.
Market Cap
2.95B
Enterprise Value
2.61B
1-Year Change
407.21%
Ranking
Category
Stock Price
$38.01
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.95B, an increase of 371.82%. That is a compound annual growth rate of 79.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 2.95B | 381.89% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |